Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 310

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review

Open access
Papp, Viktoria, Magyari, Melinda, Aktas, Orhan, Berger, Thomas, Broadley, Simon A., Cabre, Philippe, Jacob, Anu, Kira, Jun-ichi, Leite, Maria Isabel, Marignier, Romain, Miyamoto, Katsuichi, Palace, Jacqueline, Saiz, Albert, Sepulveda, Maria, Sveinsson, Olafur, Illes, Zsolt · 2021 · Neurology

Abstract

OBJECTIVE: Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica spectrum disorder (NMO/NMOSD), 22 additional studies have been conducted. We systematically review the worldwide prevalence, incidence, and basic demographic characteristics of NMOSD and provide a critical overview of studies. METHODS: PubMed, Ovid MEDLINE, and Embase using Medical Subject Headings and keyword search terms and reference lists of retrieved articles were searched from 1999 until August 2019. We collected data on the country; region; methods of case assessment and aquaporin-4 antibody (AQP4-Ab) test; study period; limitations; incidence (per 100,000 person-years); prevalence (per 100,000 persons); and age-, sex-, and ethnic group-specific incidence or prevalence. RESULTS: We identified 33 relevant articles. The results indicated the highest estimates of incidence and prevalence of NMOSD in Afro-Caribbean region (0.73/100 000 person-years [95% CI: 0.45-1.01] and 10/100 000 persons [95% CI: 6.8-13.2]). The lowest incidence and prevalence of NMOSD were found in Australia and New Zealand (0.037/100 000 person-years [95% CI: 0.036-0.038] and 0.7/100,000 persons [95% CI: 0.66-0.74]). There was prominent female predominance in adults and the AQP4-Ab-seropositive subpopulation. The incidence and prevalence peaked in middle-aged adults. African ethnicity had the highest incidence and prevalence of NMOSD, whereas White ethnicity had the lowest. No remarkable trend of incidence was described over time. CONCLUSION: NMOSD is a rare disease worldwide. Variations in prevalence and incidence have been described among different geographic areas and ethnicities. These are only partially explained by different study methods and NMO/NMOSD definitions, highlighting the need for specifically designed epidemiologic studies to identify genetic effects and etiologic factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000011153

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 310

Metadata

Authors
Papp, V., Magyari, M., Aktas, O., Berger, T., Broadley, S. A., Cabre, P., Jacob, A., Kira, J.-I., Leite, M. I., Marignier, R., Miyamoto, K., Palace, J., Saiz, A., Sepulveda, M., Sveinsson, O., & Illes, Z.
Venue
Neurology
Published
2021-01-12
Volume
96
Issue
2
Pages
59-77
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3111662366
Cited by
310
References
60
FWCI
15.40
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. https://app.cochat.ai/papers/10.1212/wnl.0000000000011153
The paper
Papp, V., Magyari, M., Aktas, O., Berger, T., Broadley, S. A., Cabre, P., Jacob, A., Kira, J.-I., Leite, M. I., Marignier, R., Miyamoto, K., Palace, J., Saiz, A., Sepulveda, M., Sveinsson, O., & Illes, Z. (2021). Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. Neurology. https://doi.org/10.1212/wnl.0000000000011153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.